ketanserin has been researched along with Cancer of Prostate in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiorino, F | 1 |
| Magli, E | 1 |
| Perissutti, E | 1 |
| Severino, B | 1 |
| Frecentese, F | 1 |
| Esposito, A | 1 |
| De Angelis, F | 1 |
| Incisivo, GM | 1 |
| Massarelli, P | 1 |
| Nencini, C | 1 |
| Di Gennaro, E | 1 |
| Budillon, A | 1 |
| Di Cintio, A | 1 |
| Santagada, V | 1 |
| Caliendo, G | 1 |
| Xiang, Q | 1 |
| Wang, C | 1 |
| Wu, T | 1 |
| Zhang, C | 1 |
| Hu, Q | 1 |
| Luo, G | 1 |
| Hu, J | 1 |
| Zhuang, X | 1 |
| Zou, L | 1 |
| Shen, H | 1 |
| Wu, X | 1 |
| Zhang, Y | 1 |
| Kong, X | 1 |
| Liu, J | 1 |
| Xu, Y | 1 |
2 other studies available for ketanserin and Cancer of Prostate
| Article | Year |
|---|---|
Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents.
Topics: Antineoplastic Agents; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screen | 2011 |
Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; CREB-Binding Protein; Drug Design; H | 2022 |